SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-015228
Filing Date
2024-02-14
Accepted
2024-02-14 16:14:58
Documents
14
Period of Report
2024-02-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20240208.htm   iXBRL 8-K 43586
2 EX-10.1 rkda-ex10_1.htm EX-10.1 48404
3 GRAPHIC img5370606_0.jpg GRAPHIC 5576
  Complete submission text file 0000950170-24-015228.txt   224064

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20240208.xsd EX-101.SCH 24851
15 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20240208_htm.xml XML 4671
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 24638353
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)